US Stock MarketDetailed Quotes

Century Therapeutics (IPSC)

Watchlist
  • 2.085
  • -0.215-9.35%
Trading Jan 16 15:37 ET
374.12MMarket Cap-6.52P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Century Therapeutics (IPSC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
12,667.72%109.16M
194.81%6.59M
1,457.09%4.17M
434.46%791K
678.79%771K
-50.29%855K
-57.01%2.24M
-48.56%268K
Operating revenue
--0
--0
12,667.72%109.16M
194.81%6.59M
1,457.09%4.17M
434.46%791K
678.79%771K
-50.29%855K
-57.01%2.24M
-48.56%268K
Cost of revenue
Gross profit
Operating expense
-17.48%29.36M
-2.43%34.66M
8.78%34.99M
10.19%140.4M
20.22%37.13M
11.98%35.58M
14.76%35.53M
-4.84%32.16M
-1.25%127.42M
-8.70%30.89M
Selling and administrative expenses
-18.16%6.84M
-6.03%7.81M
-3.83%8.41M
-4.47%33.16M
-9.71%7.76M
-7.06%8.35M
0.94%8.31M
-1.79%8.74M
8.94%34.71M
4.21%8.59M
-General and administrative expense
-18.16%6.84M
-6.03%7.81M
-3.83%8.41M
-4.47%33.16M
-9.71%7.76M
-7.06%8.35M
0.94%8.31M
-1.79%8.74M
8.94%34.71M
4.21%8.59M
Research and development costs
-17.27%22.53M
-1.33%26.86M
13.49%26.58M
15.68%107.24M
31.75%29.38M
19.48%27.23M
19.77%27.22M
-5.94%23.42M
-4.59%92.71M
-12.86%22.3M
Operating profit
15.60%-29.36M
0.26%-34.66M
336.92%74.18M
-6.89%-133.81M
-7.64%-32.96M
-10.00%-34.79M
-12.63%-34.76M
2.41%-31.31M
-1.09%-125.18M
8.07%-30.62M
Net non-operating interest income expense
-51.44%1.61M
-43.89%2.01M
-25.18%2.42M
7.17%13.01M
-17.92%2.88M
-5.19%3.31M
22.59%3.58M
45.88%3.24M
305.92%12.14M
114.42%3.51M
Non-operating interest income
-51.44%1.61M
-43.89%2.01M
-25.18%2.42M
2.60%13.01M
-17.92%2.88M
-5.19%3.31M
17.14%3.58M
23.41%3.24M
186.81%12.68M
71.22%3.51M
Non-operating interest expense
----
----
----
--0
--0
--0
--0
--0
-55.00%540K
--0
Other net income (expense)
-2,766.40%-6.67M
1,041.67%113K
-445.45%-38K
81.73%-3.97M
67.93%-4.22M
106.27%250K
99.73%-12K
105.67%11K
-117.48%-21.75M
-69,363.16%-13.16M
Special income (charges)
---6.76M
----
----
79.75%-4.33M
67.08%-4.33M
--0
--0
----
-113.65%-21.37M
---13.15M
-Less:Impairment of capital assets
--6.76M
----
----
-73.56%4.33M
-64.37%4.33M
--0
--0
----
--16.37M
--12.15M
-Less:Other special charges
----
----
----
----
----
----
----
----
-50.00%5M
--1M
Other non- operating income (expenses)
-61.20%97K
1,041.67%113K
-445.45%-38K
192.43%354K
806.67%106K
1,983.33%250K
93.55%-12K
105.67%11K
---383K
---15K
Income before tax
-10.21%-34.42M
-4.35%-32.54M
372.83%76.56M
7.43%-124.78M
14.83%-34.3M
2.78%-31.23M
3.57%-31.19M
6.64%-28.06M
-3.02%-134.79M
-27.23%-40.27M
Income tax
0
0
0
-4.84%1.79M
304.37%1.78M
-101.35%-8K
-97.68%22K
-99.92%1K
1,967.03%1.88M
-2,815.63%-869K
Net income
-10.24%-34.42M
-4.27%-32.54M
372.82%76.56M
7.40%-126.57M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
Net income continuous Operations
-10.24%-34.42M
-4.27%-32.54M
372.82%76.56M
7.40%-126.57M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
Minority interest income
Net income attributable to the parent company
-10.24%-34.42M
-4.27%-32.54M
372.82%76.56M
7.40%-126.57M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.24%-34.42M
-4.27%-32.54M
372.82%76.56M
7.40%-126.57M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
Basic earnings per share
-8.11%-0.4
0.00%-0.38
297.78%0.89
30.00%-1.61
33.85%-0.43
32.73%-0.37
32.14%-0.38
15.09%-0.45
-1.32%-2.3
-18.18%-0.65
Diluted earnings per share
-8.11%-0.4
0.00%-0.38
297.78%0.89
30.00%-1.61
33.85%-0.43
32.73%-0.37
32.14%-0.38
15.09%-0.45
-1.32%-2.3
-18.18%-0.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0012,667.72%109.16M194.81%6.59M1,457.09%4.17M434.46%791K678.79%771K-50.29%855K-57.01%2.24M-48.56%268K
Operating revenue --0--012,667.72%109.16M194.81%6.59M1,457.09%4.17M434.46%791K678.79%771K-50.29%855K-57.01%2.24M-48.56%268K
Cost of revenue
Gross profit
Operating expense -17.48%29.36M-2.43%34.66M8.78%34.99M10.19%140.4M20.22%37.13M11.98%35.58M14.76%35.53M-4.84%32.16M-1.25%127.42M-8.70%30.89M
Selling and administrative expenses -18.16%6.84M-6.03%7.81M-3.83%8.41M-4.47%33.16M-9.71%7.76M-7.06%8.35M0.94%8.31M-1.79%8.74M8.94%34.71M4.21%8.59M
-General and administrative expense -18.16%6.84M-6.03%7.81M-3.83%8.41M-4.47%33.16M-9.71%7.76M-7.06%8.35M0.94%8.31M-1.79%8.74M8.94%34.71M4.21%8.59M
Research and development costs -17.27%22.53M-1.33%26.86M13.49%26.58M15.68%107.24M31.75%29.38M19.48%27.23M19.77%27.22M-5.94%23.42M-4.59%92.71M-12.86%22.3M
Operating profit 15.60%-29.36M0.26%-34.66M336.92%74.18M-6.89%-133.81M-7.64%-32.96M-10.00%-34.79M-12.63%-34.76M2.41%-31.31M-1.09%-125.18M8.07%-30.62M
Net non-operating interest income expense -51.44%1.61M-43.89%2.01M-25.18%2.42M7.17%13.01M-17.92%2.88M-5.19%3.31M22.59%3.58M45.88%3.24M305.92%12.14M114.42%3.51M
Non-operating interest income -51.44%1.61M-43.89%2.01M-25.18%2.42M2.60%13.01M-17.92%2.88M-5.19%3.31M17.14%3.58M23.41%3.24M186.81%12.68M71.22%3.51M
Non-operating interest expense --------------0--0--0--0--0-55.00%540K--0
Other net income (expense) -2,766.40%-6.67M1,041.67%113K-445.45%-38K81.73%-3.97M67.93%-4.22M106.27%250K99.73%-12K105.67%11K-117.48%-21.75M-69,363.16%-13.16M
Special income (charges) ---6.76M--------79.75%-4.33M67.08%-4.33M--0--0-----113.65%-21.37M---13.15M
-Less:Impairment of capital assets --6.76M---------73.56%4.33M-64.37%4.33M--0--0------16.37M--12.15M
-Less:Other special charges ---------------------------------50.00%5M--1M
Other non- operating income (expenses) -61.20%97K1,041.67%113K-445.45%-38K192.43%354K806.67%106K1,983.33%250K93.55%-12K105.67%11K---383K---15K
Income before tax -10.21%-34.42M-4.35%-32.54M372.83%76.56M7.43%-124.78M14.83%-34.3M2.78%-31.23M3.57%-31.19M6.64%-28.06M-3.02%-134.79M-27.23%-40.27M
Income tax 000-4.84%1.79M304.37%1.78M-101.35%-8K-97.68%22K-99.92%1K1,967.03%1.88M-2,815.63%-869K
Net income -10.24%-34.42M-4.27%-32.54M372.82%76.56M7.40%-126.57M8.44%-36.07M4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M
Net income continuous Operations -10.24%-34.42M-4.27%-32.54M372.82%76.56M7.40%-126.57M8.44%-36.07M4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M
Minority interest income
Net income attributable to the parent company -10.24%-34.42M-4.27%-32.54M372.82%76.56M7.40%-126.57M8.44%-36.07M4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.24%-34.42M-4.27%-32.54M372.82%76.56M7.40%-126.57M8.44%-36.07M4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M
Basic earnings per share -8.11%-0.40.00%-0.38297.78%0.8930.00%-1.6133.85%-0.4332.73%-0.3732.14%-0.3815.09%-0.45-1.32%-2.3-18.18%-0.65
Diluted earnings per share -8.11%-0.40.00%-0.38297.78%0.8930.00%-1.6133.85%-0.4332.73%-0.3732.14%-0.3815.09%-0.45-1.32%-2.3-18.18%-0.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.74%
Sample Name
Sample Code
 +2.26%
4
Tempus AI
TEM
+2.21%
5
Clean Energy Fuels
CLNE
+1.36%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.95%
Sample Name
Sample Code
 +10.23%
Sample Name
Sample Code
 +9.63%
4
Kingsoft Cloud
KC
+7.53%
5
United Microelectronics
UMC
+5.97%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -